Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China

NCT03491891 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8476

Last updated 2019-09-20

Study results available
· View outcomes & findings →

Summary

The investigators sought to identify and verify the potential correlates and mechanisms of Very Late Stent Thrombosis (VLST) after the implantation of new generation drug eluting steng in China from an analysis of multicenter registries.

Conditions

  • Stent Thrombosis

Sponsors & Collaborators

  • First Affiliated Hospital of Shantou University Medical College

    collaborator OTHER
  • The First Hospital of Jilin University

    lead OTHER

Principal Investigators

  • yang zheng · Jilin University 1st Hospital Cardiovascular Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2015-06-01
Completion
2019-06-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03491891 on ClinicalTrials.gov